BioNTech

What companies are leading in innovation in Europe in 2025?

Europe's Most Innovative Companies

These companies are built to exhibit resilience amid volatility—and deliver better-than-average growth in the long term.

<p>This biotech company is best known for its work with Pfizer on one of the vaccines that helped curb COVID-19. As the pandemic receded, BioNTech’s sales dwindled; it expects revenue of about $3&nbsp;billion this year, down from $22&nbsp;billion in 2021. But investors are bullish about BioNTech’s drug pipeline, which includes therapies based on the mRNA research that underpinned the vaccine, as well as immunotherapies for fighting cancer. Treatments for non-small-cell lung cancer and metastatic breast cancer are now in Phase&nbsp;III clinical trials.</p>

The Future 50

The first-ever European edition of the Fortune 500, ranking companies by revenue. 

F500 Europe 2023 BioNTech Bettina Stark-watzinger, Federal Minister For Education And Research, Visits Biontech In Mainz

BioNTech ranks 207 with $18.2 billion in revenue (down 18.9%). The Germany-headquartered pharmaceutical company has 4,530 employees and made a profit of $9.9 billion (down 18.5%).

Fortune 500 Europe

Key Financials (last Fiscal Year)

Revenues ($M)

Profits ($M)

Assets ($M)

Total Stockholder Equity ($M)

Profit Ratios

Profit as % of Revenues

Profits as % of Assets

Profits as % of Stockholder Equity

Future 50

Overall Score

Sector

Strongest dimension

Years on list

Country

Get insights into BioNTech including business profile, stock information, news, and rankings from Fortune.

BioNTech (BNTX): Company Profile, Stock Price, News, Rankings

legacy

biontech

Companies

BioNTech | Fortune

BioNTech (BNTX): Company Profile, Stock Price, News, Rankings | Fortune

Ben Stupples

Bloomberg

Secretive German billionaire twins cut Covid vaccine bet after banking 550% gain

/europe/2023/11/06/secretive-german-billionaire-twins-struengmann-sell-biontech-vaccine-stock-shares/

European and U.S. markets soared on the announcement.

Pfizer, BioNTech say COVID vaccine 90% effective

Briefing

BioNTech

BioNTech in Fortune Rankings

BioNTech stock chart

Videos